Kate Davenport

Name:	Kate Davenport
Affiliation:	Cancer Research UK Cambridge Institute
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	25 Mar 2026, 3:22 p.m.

Public lists managed by Kate Davenport

• Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer
• Seminars on Quantitative Biology @ CRUK Cambridge Institute

Talks given by Kate Davenport

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Kate Davenport

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Kate Davenport actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Seminars in Cancer
• Seminars in Cancer
• Seminars in Cancer
• A complex TiME: How aging drives tumor progression
• Seminars in Cancer
• Targeting the interplay between oncogenic RAS signaling and tumour immune evasion in lung cancer
• Spatial mapping of breast cancer tumour microenvironment in Black British and White British women
• Unique Biology and Clinical Impact in Invasive Lobular Carcinoma
• Next generation medicine: towards eliminating the invisible in ovarian cancer
• Seminar cancelled - Spatial mapping of breast cancer tumour microenvironment in Black British and White British women
• Quantitative Biology Seminar
• Engineering genomes and proteomes as foundational biotechnology for translational research
• Steering the evolutionary dynamics of cancer through space and time
• The Roles of the Epilepsy-Associated Kinase CDKL5
• Telomere to mitochondria signaling prevents age-associated cancer initiation
• Understanding Mechanisms of Microenvironment-Mediated Therapy Resistance
• How to Fold Every Protein: (Mission Accomplished?)
• Origins and consequences of gene dosage mutations in cancer
• Protein Evolution in Sequence Landscapes - From Data to Models and Back
• Seminars in Cancer
• Endogenous Formaldehyde as a driver for clonal haematopoiesis and in pervasive DNA base adduction
• Senescent secretome shenanigans: Differential therapeutic benefit for breast cancer dictated by distinct extracellular vesicle-mediated inflammatory response
• Protein genetic architecture is simple, and epistasis can facilitate the evolution of new functions
• Quantitative Biology Seminar
• Identifying therapeutic opportunities in the metabolic crosstalk between the tumour and the host
• Digital Cancer Twins: From Mechanistic Insights to Therapeutic Applications
• The Biology of Drug Resistance in Lung Cancer
• Title to be confirmed
• Modelling and Targeting the Tumour Microenvironment of High-Grade Serous Ovarian Cancer
• Programmed evolution: Using asexual gene drives to sculpt tumor populations and combat genetic diversity
• Towards Rational Combination Therapies: Understanding tumor evolution during therapy response and resistance
• Screening Approaches for the Identification of Covalent Peptide Inhibitors
• Cell size - A new hallmark of aging?
• Deciphering Developmental Disorders
• Functional studies of genetic variation using precision genome editing
• First in human evaluation of CDK9 inhibition with KB-0742 in solid tumors
• How cilia signal
• Small Cell Lung Cancer from biology to biomarkers
• A DNA methylation atlas of normal human cell types
• Title to be confirmed
• This seminar has been cancelled - we apologise for any inconvenience caused. Thank you
• Probing the rate limitation of a cancer driver mutation
• This seminar has been cancelled - we apologise for any inconvenience caused. Thank you
• Mitochondria and Cancer - lessons learned dissecting cellular and molecular interactions
• Cell Plasticity and Lineage Commitment in Liver Tumorigenesis
• Title to be confirmed
• Deciphering the regulation and regulatory function of oncogenic transcription factors using time-resolved functional genetics
• Title to be confirmed
• Accelerating drug discovery with the power of microscopy & AI
• Genomic and digital pathology approaches to elucidate cancer dormancy
• Decoding and Recoding the Opposing Roles of Interferon and Pattern Recognition Receptor Signaling in Cancer Immunotherapy
• Seminar cancelled
• Metabolic rewiring drives invasion and metastasis in mammary carcinoma
• Priming the Immune System to Provoke Checkpoints: The Path to Maintaining the Immunotherapy Momentum
• Cell Polarity and Organoids: New Pathways and Models for Translational Research and Cancer Immunology
• Cancelled
• Quality control of proteins orphaned in the cytosol
• Regulation of Protein Degradation in Cancer and Effect on Tumor Immunity
• Mechanisms and consequences of pancreatic cancer stromal evolution
• Molecular Imaging for the Improved Visualization and Treatment of Cancer
• The remote control of gene expression: enhancer function in development and disease
• Targeting the Tumour Microenvironment
• Therapeutic Opportunities in Glycoscience
• **** This seminar has been cancelled ****
• **** This seminar has been cancelled ****
• **** This seminar has been cancelled ****
• Single cell whole genome sequencing approaches to model evolution in cancer
• Cancer and ageing: Rival demons?
• Forcing tumor initiation and progression
• Transcriptional dependencies in cancer
• TET-family dioxygenases, immune responses and cancer
• Perturbation biology: data-driven executable models of cellular processes and the design of combination therapy
• Cellular Conversations that Control Cancer
• Fire and Water are Good Servants, But Bad Masters
• A Deep Dive into the Genome of Hypoxic Tumours
• Epigenetic control of malignant melanoma
• Genome Architecture Mapping: discovering 3D genome topology in rare cell types
• Bridging DNA methylation dynamics and electronic health records to understand the non-coding genome
• Towards cancer screening using circulating DNA
• *** Cancelled***
• Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer
• Functional Genomics to Study Cancer
• Clonal evolution of cancer: lessons from the mouse
• Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain
• RNA Genomics in Health and Disease
• Transcription Factor/Chromatin Interactions: Integrating Genomics and Live Cell Dynamics
• Mechanosensing and endosomal traffic – new vulnerabilities in breast cancer
• Dangerous Liaisons between platelets and cancer
• Genomic Approaches to Cancer
• Biomolecular condensates and their implications for neurodegenerative disease
• ***PLEASE NOTE THIS SEMINAR IS CANCELLED***
• ****CANCELLED***Mammalian SWI/SNF (BAF) complex structure and function in human cancer
• MYC and Metabolic Vulnerabilities of Cancer
• Epigenomic pathways in cancer and in cancer immunotherapy
• Overcoming Chromatin Barriers to Elicit Cell Fate Changes
• What can we learn from Cancer Genomes?
• The Cancer Cell Map Initiative
• SEMINAR CANCELLED
• Studies into the biology of metastatic disease reveals tRNA-derived fragments that suppress cancer progression
• *Please note that this talk has been cancelled*
• Using Mouse Models to Understand Metastatic Spread and Tumour Heterogeneity
• *Please note that this talk has been cancelled and re-scheduled for 2017*
• Understanding and targeting the ovarian cancer microenvironment
• Tumour suppressor and tumour maintenance genes
• DNMT3A in Hematopoietic Stem Cells, Cancer and Ageing
• Proteomics in cell signaling and cancer research
• Using RNA-based approaches to identify and characterise cancer genes
• The use of recent advances in electron microscopy to study the ribosome
• The role of dsRNA in cellular response to genetic change
• The role of macrophages in tumour progression and metastasis
• Whole-exome sequencing identifies recurrent functional mutations in melanoma
• TALK CANCELLED
• Clinical Systems Medicine in Acute Myeloid Leukemia and Beyond
• NextGen Research: Enabling distributed teams of experts and the engaged public to solve complex biomedical problems
• Harnessing Genetic Dependencies in Cancer Therapy
• Hallmarks of Cancer: Applications to Cancer Medicine?
• Modeling Tumorigenesis and Drug Resistance in Three Dimensions
• Chromatin and its Impact on Gene Expression and Cellular Memory
• Inflammation and Cancer: Reprogramming the immune microenvironment as an anti-cancer therapeutic strategy
• HER2 and EGFR: Signalling mechanisms and next generation cancer therapies
• Duplicating the Human genome: The Origin Recognition Complex et al
• Genetic network interactions and cancer susceptibility
• The impact of cohesin on the regulation of gene expression and the organization of chromatin
• Impact of cancer- and stroma-cell-derived lysosomal proteases on cancer invasion and metastasis
• Recapturing pluripotency: links between cellular reprogramming and breast cancer heterogenity
• Molecular dissection and targeting of epigenetic machinery in AML stem cells
• Cancer cell metabolism - basic biology and translational approaches
• The regulation of gene expression in the context of chromatin
• PLEASE NOTE THAT THIS TALK HAS BEEN CANCELLED
• The Ras pathway in cancer therapy
• The role of telomeres and telomerase in stem cell biology, cancer and ageing
• Cellular Conversations that Control Cell Fate
• Title to be confirmed
• Common and rare variants in the sequence of the human genome that affect the risk of cancers and other diseases of man
• Towards unification of genetic and hierarchy models of tumor heterogeneity
• Pluripotency, Etc.
• Chromosome Segregation and Genome Stability
• Inflammatory skin disease and Cancer: Functions of AP-1 (Fos/Jun) in mice and humans
• The intrinsic and extrinsic regulation of stem cells self-renewal
• Transcriptional Regulation of Cell State
• Understanding the molecular and cellular nature of undifferentiated stem cell 'states'
• Modeling non-familial colon cancer susceptibility in mice
• Integrated Solutions in Cancer Genomics
• Changing Cancer Mortality
• Modeling non-familial colon cancer susceptibility in mice
• Analysis of Sprouty2 in human prostate carcinogenesis
• Inflammation, metabolism, ageing and cancer: Dangerous Liaisons
• Biological lessons from presurgical studies of breast cancer